As part of his studies on Psychiatry, David Pickar often connects relevant areas like Pharmacotherapy. Schizophrenia (object-oriented programming) is closely attributed to Clozapine in his research. Clozapine and Schizophrenia (object-oriented programming) are commonly linked in his work. With his scientific publications, his incorporates both Clinical psychology and Psychopathology. He performs multidisciplinary study in the fields of Psychopathology and Clinical psychology via his papers. David Pickar incorporates Cognition and Psychomotor learning in his research. In his research, David Pickar undertakes multidisciplinary study on Psychomotor learning and Cognition. David Pickar merges Intensive care medicine with Psychiatry in his research. His work on Law expands to the thematically related MEDLINE.
David Pickar regularly links together related areas like Anxiety in his Psychiatry studies. His Internal medicine study frequently links to adjacent areas such as Hormone. His Hormone study often links to related topics such as Internal medicine. Schizophrenia (object-oriented programming) is closely attributed to Clozapine in his study. His research links Schizophrenia (object-oriented programming) with Clozapine. His study connects beta-Endorphin and Endocrinology. His research brings together the fields of Endocrinology and beta-Endorphin. His study ties his expertise on Dopamine together with the subject of Neuroscience. He combines topics linked to Neuroscience with his work on Dopamine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
Alan Breier;T. P. Su;R. Saunders;R. E. Carson.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
P. W. Gold;D. L. Loriaux;A. Roy;M. A. Kling.
The New England Journal of Medicine (1986)
National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia: Prognosis and Predictors of Outcome
Alan Breier;Judith L. Schreiber;Janyce Dyer;David Pickar.
Archives of General Psychiatry (1991)
NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers
Anil K. Malhotra;Debra A. Pinals;Herbert Weingartner;Karen Sirocco.
Effort and Cognition in Depression
Robert M. Cohen;Herbert Weingartner;Sheila A. Smallberg;David Pickar.
Archives of General Psychiatry (1982)
Cognitive effects of corticosteroids.
Owen M. Wolkowitz;Victor I. Reus;Victor I. Reus;Victor I. Reus;Herbert Weingartner;Herbert Weingartner;Herbert Weingartner;Karen Thompson;Karen Thompson;Karen Thompson.
American Journal of Psychiatry (1990)
Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers
Tung Ping Su;Michael Pagliaro;Peter J. Schmidt;David Pickar.
Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders.
Monte S. Buchsbaum;Lynn E. DeLisi;Henry H. Holcomb;John Cappelletti.
Archives of General Psychiatry (1984)
Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.
David Pickar;Richard R. Owen;Robert E. Litman;P. Eric Konicki.
Archives of General Psychiatry (1992)
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery
T E Goldberg;J M Gold;R Greenberg;S Griffin.
American Journal of Psychiatry (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: